Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis
Clinical trial NCT00838565 · COMPLETED
Trial details
- NCT number
- NCT00838565
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-20
- Primary completion
- 2012-02-02
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.